Breaking News Instant updates and real-time market news.

AGRX

Agile Therapeutics

$1.86 /

+0.045 (+2.48%)

11:03
04/30/21
04/30
11:03
04/30/21
11:03

Agile Therapeutics presents Twirla data at ACOG Annual Meeting

Agile Therapeutics announced that a post hoc analysis of the Phase 3 SECURE Trial evaluating the safety and efficacy of Twirla transdermal system in women with BMI less than 25 kg/m2 and women with BMI 25-30 kg/m2 will be presented at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting from April 30 - May 2. Twirla was approved based on the Phase 3 SECURE Trial, a United States, multicenter, single-arm, open-label, 13-cycle trial that evaluated the efficacy, safety and tolerability of Twirla in 2,032 healthy women. Twirla is a combination of levonorgestrel and ethinyl estradiol indicated as a method of contraception for use in women of reproductive potential with a BMI less than 30 kg/m2 for whom a combined hormonal contraceptive is appropriate. The U.S. package insert also includes a Limitation of Use statement guiding prescribers to consider Twirla's reduced effectiveness in women with a BMI greater than or equal to 25 to less than 30 kg/m2 before prescribing. Twirla is contraindicated in women with a BMI greater than or equal to 30 kg/m2. This post hoc analysis of SECURE assessed the efficacy, safety and tolerability of Twirla in women with BMI less than 25 kg/m2 and BMI 25-30 kg/m2. When compared to women with BMI less than 25 kg/m2, Twirla demonstrated lower but acceptable efficacy while maintaining similar safety and tolerability in women with BMI 25-30 kg/m2. "The results of this post hoc analysis help to inform providers counseling women that fall within BMI 25-30 kg/m2 who may be considering a non-oral, noninvasive contraception option," said Anita Nelson, MD, Lead Author and Primary Investigator in the SECURE study. "These data support the safety and tolerability of Twirla in women within BMI 25-30 kg/m2 as well as those with BMI less than 25 kg/m2."

  • 04

    May

  • 08

    Jun

AGRX Agile Therapeutics
$1.86 /

+0.045 (+2.48%)

04/06/21 RBC Capital
Agile Therapeutics transferred with an Outperform at RBC Capital
12/08/20 H.C. Wainwright
Agile Therapeutics price target raised to $7 from $6 at H.C. Wainwright
09/22/20 H.C. Wainwright
H.C. Wainwright says Agile coverage, access for Twirla launch underappreciated

TODAY'S FREE FLY STORIES

Recommendations
Alfa Laval price target raised to SEK 365 from SEK 345 at Credit Suisse » 13:33
10/28/21
10/28
13:33
10/28/21
13:33
ALFVY

Alfa Laval

$41.39 /

+1.14 (+2.83%)

Credit Suisse analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALFVY Alfa Laval
$41.39 /

+1.14 (+2.83%)

10/27/21 Morgan Stanley
Alfa Laval price target raised to SEK 327 from SEK 312 at Morgan Stanley
10/27/21 RBC Capital
Alfa Laval price target raised to SEK 400 from SEK 370 at RBC Capital
09/28/21 Morgan Stanley
Alfa Laval price target raised to SEK 312 from SEK 300 at Morgan Stanley
09/06/21 Credit Suisse
Alfa Laval downgraded to Neutral from Outperform at Credit Suisse
Recommendations
UPM-Kymmene price target lowered to EUR 35.50 from EUR 37 at Credit Suisse » 13:32
10/28/21
10/28
13:32
10/28/21
13:32
UPMMY

UPM-Kymmene

$36.24 /

+0.22 (+0.61%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPMMY UPM-Kymmene
$36.24 /

+0.22 (+0.61%)

10/27/21 UBS
UPM-Kymmene price target raised to EUR 32.90 from EUR 31.80 at UBS
09/28/21 UBS
UPM-Kymmene price target lowered to EUR 31.80 from EUR 33.70 at UBS
09/13/21 Danske Bank
UPM-Kymmene downgraded to Sell from Hold at Danske Bank
07/26/21 Credit Suisse
UPM-Kymmene price target raised to EUR 37 from EUR 34.50 at Credit Suisse
Earnings
HP Enterprise sees compound annual revenue growth rate of 2-4% in FY22-FY24 » 13:32
10/28/21
10/28
13:32
10/28/21
13:32
HPE

HP Enterprise

$14.64 /

+0.05 (+0.34%)

HPE provided its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
07/25/21 Evercore ISI
HP Enterprise upgraded to Outperform from In Line at Evercore ISI
HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

HPE HP Enterprise
$14.64 /

+0.05 (+0.34%)

Recommendations
Banco Santander price target raised to EUR 3.60 from EUR 3.50 at Credit Suisse » 13:32
10/28/21
10/28
13:32
10/28/21
13:32
SAN

Banco Santander

$3.85 /

+0.06 (+1.59%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAN Banco Santander
$3.85 /

+0.06 (+1.59%)

SAN Banco Santander
$3.85 /

+0.06 (+1.59%)

13:12 Today Deutsche Bank
Banco Santander price target raised to EUR 3.90 from EUR 3.85 at Deutsche Bank
13:00 Today UBS
Banco Santander price target raised to EUR 4.35 from EUR 4.20 at UBS
10/18/21 Barclays
Banco Santander price target raised to EUR 4.30 from EUR 4 at Barclays
10/15/21 UBS
Banco Santander price target raised to EUR 4.20 from EUR 4.15 at UBS
SAN Banco Santander
$3.85 /

+0.06 (+1.59%)

SAN Banco Santander
$3.85 /

+0.06 (+1.59%)

Recommendations
Just Eat Takeaway price target raised to 9,300 GBp at Credit Suisse » 13:31
10/28/21
10/28
13:31
10/28/21
13:31
GRUB

Just Eat Takeaway

$14.53 /

-0.605 (-4.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRUB Just Eat Takeaway
$14.53 /

-0.605 (-4.00%)

GRUB Just Eat Takeaway
$14.53 /

-0.605 (-4.00%)

10/22/21 Barclays
Just Eat Takeaway price target lowered to 8,910 GBp from 8,930 GBp at Barclays
10/19/21 JPMorgan
Just Eat Takeaway price target raised to 8,695 GBp from 8,448 GBp at JPMorgan
10/19/21 Deutsche Bank
Just Eat Takeaway price target lowered to 5,916 GBp at Deutsche Bank
10/15/21 Morgan Stanley
Just Eat Takeaway price target lowered to 9,900 GBp at Morgan Stanley
GRUB Just Eat Takeaway
$14.53 /

-0.605 (-4.00%)

GRUB Just Eat Takeaway
$14.53 /

-0.605 (-4.00%)

GRUB Just Eat Takeaway
$14.53 /

-0.605 (-4.00%)

Recommendations
Puma price target raised to EUR 108 from EUR 102 at Credit Suisse » 13:30
10/28/21
10/28
13:30
10/28/21
13:30
PUMSY

Puma

$12.11 /

+0.23 (+1.94%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PUMSY Puma
$12.11 /

+0.23 (+1.94%)

13:00 Today UBS
Puma price target raised to EUR 119 from EUR 117 at UBS
11:57 Today Societe Generale
Puma price target raised to EUR 122 from EUR 120 at Societe Generale
10/11/21 JPMorgan
Puma price target lowered to EUR 135 from EUR 145 at JPMorgan
08/25/21 Deutsche Bank
Puma upgraded to Buy from Hold at Deutsche Bank
Recommendations
Lancashire price target lowered to 760 GBp from 858 GBp at Credit Suisse » 13:30
10/28/21
10/28
13:30
10/28/21
13:30
LCSHF

Lancashire

$7.13 /

+0.11 (+1.57%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LCSHF Lancashire
$7.13 /

+0.11 (+1.57%)

10/22/21 Barclays
Lancashire price target lowered to 787 GBp from 871 GBp at Barclays
10/20/21 Berenberg
Lancashire price target lowered to 800 GBp from 915 GBp at Berenberg
10/18/21 UBS
Lancashire price target lowered to 810 GBp from 872 GBp at UBS
09/10/21 Barclays
Lancashire price target lowered to 871 GBp from 907 GBp at Barclays
Earnings
HP Enterprise sees FY22 revenue growth to be 3-4% in constant currency » 13:29
10/28/21
10/28
13:29
10/28/21
13:29
HPE

HP Enterprise

$14.64 /

+0.055 (+0.38%)

Consensus for FY22…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
07/25/21 Evercore ISI
HP Enterprise upgraded to Outperform from In Line at Evercore ISI
HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

HPE HP Enterprise
$14.64 /

+0.055 (+0.38%)

Earnings
HP Enterprise sees FY22 non-GAAP EPS $1.96-$2.10, consensus $1.98 » 13:27
10/28/21
10/28
13:27
10/28/21
13:27
HPE

HP Enterprise

$14.65 /

+0.065 (+0.45%)

Hewlett Packard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
07/25/21 Evercore ISI
HP Enterprise upgraded to Outperform from In Line at Evercore ISI
HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

HPE HP Enterprise
$14.65 /

+0.065 (+0.45%)

Hot Stocks
Facebook says 'GTA: San Andreas' VR game in development for Oculus Quest 2 » 13:27
10/28/21
10/28
13:27
10/28/21
13:27
FB

Facebook

$314.75 /

+2.43 (+0.78%)

, TTWO

Take-Two

$179.36 /

-1.525 (-0.84%)

Facebook (FB) CEO Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$314.75 /

+2.43 (+0.78%)

TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

FB Facebook
$314.75 /

+2.43 (+0.78%)

10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

10/27/21 JPMorgan
Take-Two price target raised to $200 from $190 at JPMorgan
09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 BMO Capital
Take-Two downgraded to Market Perform from Outperform at BMO Capital
09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
FB Facebook
$314.75 /

+2.43 (+0.78%)

TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

FB Facebook
$314.75 /

+2.43 (+0.78%)

TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

FB Facebook
$314.75 /

+2.43 (+0.78%)

TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

FB Facebook
$314.75 /

+2.43 (+0.78%)

TTWO Take-Two
$179.36 /

-1.525 (-0.84%)

Recommendations
Integra LifeSciences new CEO 'seems solid,' says Piper Sandler » 13:26
10/28/21
10/28
13:26
10/28/21
13:26
IART

Integra LifeSciences

$66.72 /

-1.875 (-2.73%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IART Integra LifeSciences
$66.72 /

-1.875 (-2.73%)

IART Integra LifeSciences
$66.72 /

-1.875 (-2.73%)

09/15/21
Fly Intel: Top five analyst downgrades
09/15/21 BTIG
Integra LifeSciences downgraded to Neutral from Buy at BTIG
07/28/21 Piper Sandler
Integra update on Acell to weigh on shares, says Piper Sandler
06/24/21 Piper Sandler
Integra's CEO transition leaves cautious view unchanged, says Piper Sandler
IART Integra LifeSciences
$66.72 /

-1.875 (-2.73%)

Hot Stocks
Facebook CEO says live services games to be big part of metaverse » 13:25
10/28/21
10/28
13:25
10/28/21
13:25
FB

Facebook

$315.00 /

+2.68 (+0.86%)

Says gaming is how many…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$315.00 /

+2.68 (+0.86%)

FB Facebook
$315.00 /

+2.68 (+0.86%)

10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
FB Facebook
$315.00 /

+2.68 (+0.86%)

FB Facebook
$315.00 /

+2.68 (+0.86%)

FB Facebook
$315.00 /

+2.68 (+0.86%)

FB Facebook
$315.00 /

+2.68 (+0.86%)

Options
FuelCell call volume above normal and directionally bullish » 13:25
10/28/21
10/28
13:25
10/28/21
13:25
FCEL

FuelCell

$7.60 /

+0.61 (+8.73%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCEL FuelCell
$7.60 /

+0.61 (+8.73%)

FCEL FuelCell
$7.60 /

+0.61 (+8.73%)

09/15/21 B. Riley
FuelCell price target lowered to $8 from $10 at B. Riley
06/11/21 B. Riley
FuelCell price target lowered to $10 from $11 at B. Riley
06/11/21 Canaccord
FuelCell price target lowered to $9.00 from $13.50 at Canaccord
04/19/21 Wells Fargo
Wells Fargo starts FuelCell at Underweight, sees commercialization behind peers
FCEL FuelCell
$7.60 /

+0.61 (+8.73%)

  • 02
    Dec
FCEL FuelCell
$7.60 /

+0.61 (+8.73%)

FCEL FuelCell
$7.60 /

+0.61 (+8.73%)

General news
The Treasury's $62 B 7-year auction was mixed » 13:25
10/28/21
10/28
13:25
10/28/21
13:25
$ECON

Economic Data

/

+

The Treasury's $62 B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Kirkland's participates in a conference call with Benchmark » 13:25
10/28/21
10/28
13:25
10/28/21
13:25
KIRK

Kirkland's

$22.64 /

+0.855 (+3.93%)

Analyst Lawrence holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIRK Kirkland's
$22.64 /

+0.855 (+3.93%)

KIRK Kirkland's
$22.64 /

+0.855 (+3.93%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Benchmark
Kirkland's initiated with a Buy at Benchmark
09/03/21 Craig-Hallum
Kirkland's price target raised to $40 from $37 at Craig-Hallum
04/06/21 Sidoti
Kirkland's re-initiated with a Buy at Sidoti
KIRK Kirkland's
$22.64 /

+0.855 (+3.93%)

KIRK Kirkland's
$22.64 /

+0.855 (+3.93%)

Recommendations
Abiomed's cut guidance still above original plan, says Piper Sandler » 13:21
10/28/21
10/28
13:21
10/28/21
13:21
ABMD

Abiomed

$345.85 /

+1.32 (+0.38%)

After Abiomed reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABMD Abiomed
$345.85 /

+1.32 (+0.38%)

ABMD Abiomed
$345.85 /

+1.32 (+0.38%)

13:20 Today Piper Sandler
Abiomed 's cut guidance still above original plan, says Piper Sandler
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
08/06/21 Deutsche Bank
Abiomed price target raised to $410 from $360 at Deutsche Bank
06/18/21 Deutsche Bank
Abiomed initiated with a Buy at Deutsche Bank
ABMD Abiomed
$345.85 /

+1.32 (+0.38%)

ABMD Abiomed
$345.85 /

+1.32 (+0.38%)

Periodicals
Impossible Foods eyeing $7B valuation in fundraising, Bloomberg reports » 13:21
10/28/21
10/28
13:21
10/28/21
13:21
BYND

Beyond Meat

$97.41 /

+1.82 (+1.90%)

Plant-based meat producer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

10/27/21 Canaccord
Beyond Meat price target lowered to $100 from $125 at Canaccord
10/26/21
Fly Intel: Top five analyst downgrades
10/26/21 Credit Suisse
Credit Suisse downgrades Beyond Meat to Underperform, sees no 'quick fix'
10/26/21 Credit Suisse
Beyond Meat downgraded to Underperform from Neutral at Credit Suisse
BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

BYND Beyond Meat
$97.41 /

+1.82 (+1.90%)

Hot Stocks
Facebook says building Horizon marketplace for virtual items and products » 13:20
10/28/21
10/28
13:20
10/28/21
13:20
FB

Facebook

$315.02 /

+2.7 (+0.86%)

Says VR headset users can…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$315.02 /

+2.7 (+0.86%)

FB Facebook
$315.02 /

+2.7 (+0.86%)

10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
FB Facebook
$315.02 /

+2.7 (+0.86%)

FB Facebook
$315.02 /

+2.7 (+0.86%)

FB Facebook
$315.02 /

+2.7 (+0.86%)

FB Facebook
$315.02 /

+2.7 (+0.86%)

Hot Stocks
Fluor awarded DOE contract to execute $21B SRS integration completion contract » 13:20
10/28/21
10/28
13:20
10/28/21
13:20
FLR

Fluor

$19.34 /

+1.18 (+6.50%)

, BWXT

BWX Technologies

$60.16 /

+4.13 (+7.37%)

Fluor Corporation (FLR)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLR Fluor
$19.34 /

+1.18 (+6.50%)

BWXT BWX Technologies
$60.16 /

+4.13 (+7.37%)

FLR Fluor
$19.34 /

+1.18 (+6.50%)

10/22/21 BofA
Fluor resumed with an Underperform at BofA
10/22/21 BofA
Fluor resumed with an Underperform at BofA
08/06/21 Baird
Fluor's 'noisy' results, 'weak' backlog incrementally negative, says Baird
07/22/21 Citi
Fluor price target lowered to $20 from $23 at Citi
BWXT BWX Technologies
$60.16 /

+4.13 (+7.37%)

09/21/21 Morgan Stanley
New AUKUS pact could benefit General Dynamics, Raytheon, says Morgan Stanley
06/23/21 Credit Suisse
BWX Technologies downgraded to Neutral from Outperform at Credit Suisse
04/08/21 Maxim
BWX Technologies price target raised to $80 from $75 at Maxim
01/07/21 Baird
BWX Technologies downgraded to Neutral from Outperform at Baird
FLR Fluor
$19.34 /

+1.18 (+6.50%)

BWXT BWX Technologies
$60.16 /

+4.13 (+7.37%)

  • 10
    Feb
FLR Fluor
$19.34 /

+1.18 (+6.50%)

FLR Fluor
$19.34 /

+1.18 (+6.50%)

FLR Fluor
$19.34 /

+1.18 (+6.50%)

Options
Corvus Pharmaceuticals options imply 9.9% move in share price post-earnings » 13:19
10/28/21
10/28
13:19
10/28/21
13:19
CRVS

Corvus Pharmaceuticals

$4.46 /

-0.08 (-1.76%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$4.46 /

-0.08 (-1.76%)

CRVS Corvus Pharmaceuticals
$4.46 /

-0.08 (-1.76%)

09/22/21 Roth Capital
Corvus recent rally due to AstraZeneca data, says Roth Capital
08/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target lowered to $5 from $10 at Cantor Fitzgerald
08/03/21 Mizuho
Corvus Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
07/16/21 H.C. Wainwright
Corvus Pharmaceuticals price target lowered to $6 from $9.50 at H.C. Wainwright
CRVS Corvus Pharmaceuticals
$4.46 /

-0.08 (-1.76%)

  • 12
    Feb
CRVS Corvus Pharmaceuticals
$4.46 /

-0.08 (-1.76%)

CRVS Corvus Pharmaceuticals
$4.46 /

-0.08 (-1.76%)

Recommendations
Scor price target raised by 13% to EUR 32 at Citi » 13:18
10/28/21
10/28
13:18
10/28/21
13:18
SCRYY

Scor

$3.18 /

+0.305 (+10.61%)

Citi analyst James Shuck…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCRYY Scor
$3.18 /

+0.305 (+10.61%)

09/20/21 JPMorgan
Scor price target raised to EUR 31.90 from EUR 31.10 at JPMorgan
09/17/21 UBS
Scor price target raised to EUR 25 from EUR 24.20 at UBS
09/13/21 Deutsche Bank
Scor price target lowered to EUR 33 from EUR 36 at Deutsche Bank
09/10/21 Societe Generale
Scor price target raised to EUR 26 from EUR 25 at Societe Generale
Technical Analysis
NASDAQ market internals summary » 13:17
10/28/21
10/28
13:17
10/28/21
13:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Recommendations
Equinor price target lowered to NOK 270 from NOK 290 at RBC Capital » 13:16
10/28/21
10/28
13:16
10/28/21
13:16
EQNR

Equinor

$25.92 /

-0.13 (-0.50%)

RBC Capital analyst Biraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQNR Equinor
$25.92 /

-0.13 (-0.50%)

EQNR Equinor
$25.92 /

-0.13 (-0.50%)

05:06 Today Danske Bank
Equinor downgraded to Sell from Hold at Danske Bank
10/14/21 Danske Bank
Equinor downgraded to Hold from Buy at Danske Bank
10/12/21 Morgan Stanley
Equinor cut to Underweight at Morgan Stanley ahead of gas prices weakening
10/12/21 Morgan Stanley
Equinor downgraded to Underweight from Equal Weight at Morgan Stanley
EQNR Equinor
$25.92 /

-0.13 (-0.50%)

Recommendations
Deutsche Bank price target raised to EUR 11.50 from EUR 11 at RBC Capital » 13:16
10/28/21
10/28
13:16
10/28/21
13:16
DB

Deutsche Bank

$12.88 /

+0.13 (+1.02%)

RBC Capital analyst Anke…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

10/20/21 UBS
UBS upgrades Deutsche Bank to Buy, says could become 'cash return story'
10/20/21 UBS
Deutsche Bank upgraded to Buy from Neutral at UBS
09/17/21 JPMorgan
Deutsche Bank price target raised to EUR 13.50 from EUR 13 at JPMorgan
08/13/21
Fly Intel: Top five analyst upgrades
DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

DB Deutsche Bank
$12.88 /

+0.13 (+1.02%)

Hot Stocks
Facebook CEO says metaverse building blocks starting to 'take shape' » 13:16
10/28/21
10/28
13:16
10/28/21
13:16
FB

Facebook

$314.86 /

+2.54 (+0.81%)

Facebook CEO Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$314.86 /

+2.54 (+0.81%)

FB Facebook
$314.86 /

+2.54 (+0.81%)

10/27/21 Bernstein
Google wins 'hide and seek,' says Bernstein
10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
FB Facebook
$314.86 /

+2.54 (+0.81%)

FB Facebook
$314.86 /

+2.54 (+0.81%)

FB Facebook
$314.86 /

+2.54 (+0.81%)

FB Facebook
$314.86 /

+2.54 (+0.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.